Nice article. Confirmed what i think could happen here, which is a fast tracking of a phase 3 trial. If significant improvements are made in more than a handful of the 148 trial patients, the FDA will make sure this drug is available pronto IMO. Big pharma would be all over us.
Still a coin flip but things seem to be going in our and sufferers direction.
News 
Market Data 
Discover 
